Medicare Advantage contract
H7323 Wellcare
Local CCP · Parent: Centene Corporation
⚠ Non-renewal
Latest enrollment
6,221
2025-01
Year-over-year
+6.6%
contract book
National MA share
+0.0%
rank #440 of 936
Overall stars (latest)
★★★ 3.0
summary rating
Enrollment trend · 5 years
Star rating history
| Year | Overall | Part C | Part D | Δ |
|---|---|---|---|---|
| 2020 | — | — | — | — |
| 2021 | — | — | — | — |
| 2022 | — | — | 3.0 | — |
| 2023 | ★★½ 2.5 | 2.5 | 2.5 | — |
| 2024 | ★★★ 3.0 | 2.5 | 3.0 | +0.5 |
Premium
Median monthly plan premium across this contract's plans, by year.
| Plan | Year | Monthly premium | Part D premium |
|---|---|---|---|
| H7323-007 | 2026 | $0.00 | $0.00 |
| H7323-012 | 2026 | $0.00 | $0.00 |
Premium analytics
Deeper cuts for investors and plan-strategy teams, delivered as a custom analysis.
Measure-level star movers
2023 → 2024- C24 Care Coordination 1★ → 4★
- C16 Statin Therapy for Patients with Cardiovascular Disease 5★ → 2★
- D04 Drug Plan Quality Improvement 2★ → 5★
- C10 Diabetes Care Blood Sugar Controlled 5★ → 2★
- C17 Transitions of Care 3★ → 1★
- C01 Breast Cancer Screening 4★ → 2★
🔒 Want a custom analysis on this? — which measures moved, cut-point sensitivity, and
projected next-year exposure.
Talk to us →
County enrollment
0 counties| State | County | Enrollment |
|---|
Want a custom analysis on this?
Talk to us →County market share vs. competitors
service-area overlapHead-to-head share by county against named competitors, with expansion whitespace and defended turf.
Want a custom analysis on this?
Talk to us →